We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tyra Biosciences Inc is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Tyra Biosciences Inc is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer.
Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights PR Newswire CARLSBAD, Calif., March 19, 2024 - Advanced SURF301 Phase 1 oncology study; Initial Phase 1...
Tyra Biosciences to Present at Upcoming Investor Conferences PR Newswire CARLSBAD, Calif., Feb. 27, 2024 CARLSBAD, Calif., Feb. 27, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 2.76 | 18.2902584493 | 15.09 | 19.29 | 15.09 | 123342 | 17.5136066 | CS |
4 | -0.24 | -1.32669983416 | 18.09 | 19.29 | 14.12 | 125094 | 15.99339914 | CS |
12 | -0.22 | -1.21748754842 | 18.07 | 20.67 | 14.12 | 129578 | 17.29090167 | CS |
26 | 4.71 | 35.8447488584 | 13.14 | 20.67 | 10.6004 | 113256 | 15.88039446 | CS |
52 | 5.84 | 48.6261448793 | 12.01 | 20.67 | 10.38 | 90103 | 15.51977093 | CS |
156 | -12.05 | -40.3010033445 | 29.9 | 31.36 | 4.93 | 101664 | 14.56246576 | CS |
260 | -12.05 | -40.3010033445 | 29.9 | 31.36 | 4.93 | 101664 | 14.56246576 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions